Recombinant human thrombopoietin for chronic liver disease-associated thrombocytopenia with or without concomitant infections: a real-world retrospective study.

Front Pharmacol · 2026 · PMC13050849 · PMID 41948720

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In patients with baseline PLT ≥50 × 10 9 /L, cirrhosis also showed a trend toward delayed response ( Figure 5D ). 4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.